PRO-DEX, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PRO-DEX, INC. (PDEX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$183.00 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-11
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $510.00K, a 68.34% decline year-over-year.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$367.00K, a 252.28% decline year-over-year.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$326.00K.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$206.00K.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.59M.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.51M, a 568.42% decline from fiscal 2014.
- PRO-DEX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $323.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $143.00K derived: sum of 2 quarters · filed 2017-05-11 | -$183.00K 10-Q · filed 2017-05-11 | -$389.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | -$367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$693.00K 10-Q · filed 2017-02-09 | -$899.00K derived: sum of 3 quarters · filed 2017-02-09 | $712.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-09-30 | -$326.00K 10-Q · filed 2016-11-10 | -$532.00K derived: sum of 2 quarters · filed 2016-11-10 | $1.08M derived: sum of 3 quarters · filed 2017-05-11 | $1.32M derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-06-30 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-15 | $1.41M derived: sum of 2 quarters · filed 2017-05-11 | $1.65M derived: sum of 3 quarters · filed 2017-05-11 | $1.59M 10-K · filed 2016-09-15 |
| 2016-03-31 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $1.85M derived: sum of 2 quarters · filed 2017-05-11 | $1.79M 10-Q · filed 2017-05-11 | $1.36M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $183.00K 10-Q · filed 2017-02-09 | -$250.00K derived: sum of 3 quarters · filed 2017-02-09 | $47.00K derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-09-30 | -$58.00K 10-Q · filed 2016-11-10 | -$491.00K derived: sum of 2 quarters · filed 2016-11-10 | -$194.00K derived: sum of 3 quarters · filed 2016-11-10 | -$1.47M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-15 | -$136.00K derived: sum of 2 quarters · filed 2016-09-15 | -$1.42M derived: sum of 3 quarters · filed 2016-09-15 | -$1.51M 10-K · filed 2016-09-15 |
| 2015-03-31 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$983.00K derived: sum of 2 quarters · filed 2016-05-12 | -$1.08M 10-Q · filed 2016-05-12 | -$444.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | -$1.38M 10-Q · filed 2016-02-11 | -$741.00K derived: sum of 3 quarters · filed 2016-02-11 | |
| 2014-09-30 | -$97.00K 10-Q · filed 2015-11-10 | $539.00K derived: sum of 2 quarters · filed 2015-11-10 | ||
| 2014-06-30 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-17 | $323.00K 10-K · filed 2015-09-17 | ||
| 2014-03-31 | -$313.00K 10-Q · filed 2014-05-12 | |||
| 2013-03-31 | -$68.00K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |